Clinical Trial Update: Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety and effectiveness of OROS Hydromorphone Slow-Release for chronic low back pain. The study also assessed impact on pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• OROS Hydromorphone Slow-Release (hydromorphone)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED